BIOMAT Database Logo BIOMAT Database Logo

Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man. 1975

E K Syvälahti, and J H Kanto

The effect of diazepam on blood glucose, serum immunoreactive insulin (IRI), and growth hormone (GH) were studied in 10 volunteers who received diazepam in oral doses of 5 and 10 mg, and intravenously 10 mg. They also received placebo and saline treatment. There was a dose-dependent rise in GH after diazepam administration, and the rise was related to the peak plasma level of the drug. A highly significant correlation between the concentrations of serum GH and plasma diazepam was found. During the i.v. and oral administration of 10 mg of diazepam, the peak GH levels, reached in 30 and 60 minutes (19.6+/-2.9 and 15.2+/-3.2ng/ml, respectively), were significantly higher than those during saline and placebo periods (4.3+/-0.8 and 5.9+/-1.1 ng/ml, respectively). There was a tendency to a rise of blood glucose levels, but no significant changes of serum IRI.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E K Syvälahti, and J H Kanto
Serum growth hormone, serum immunoreactive insulin and blood glucose response to intravenous tolbutamide in postmenopausal women with and without natural oestrogen therapy.
March 1976, Acta pharmacologica et toxicologica,
E K Syvälahti, and J H Kanto
Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man.
July 1972, Journal of applied physiology,
E K Syvälahti, and J H Kanto
Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
June 1972, Israel journal of medical sciences,
E K Syvälahti, and J H Kanto
Blood glucose, serum insulin and growth hormone response to intravenous administration of arginine in premature infants.
January 1972, Biology of the neonate,
E K Syvälahti, and J H Kanto
Blood glucose, serum immunoreactive insulin and growth hormone responses to intravenous infusion of an aminoacids mixture in healthy subjects and diabetics.
March 1977, The Journal of the Association of Physicians of India,
E K Syvälahti, and J H Kanto
Glucose and immunoreactive insulin disappearance from the circulation following intravenous insulin administration, and the growth hormone response.
October 1969, Clinical science,
E K Syvälahti, and J H Kanto
Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man.
January 1994, European journal of clinical pharmacology,
E K Syvälahti, and J H Kanto
Serum growth hormone, insulin and blood sugar responses to oral glucose in protein energy malnutrition.
January 1989, Tropical and geographical medicine,
E K Syvälahti, and J H Kanto
Effect of illness on serum growth hormone response to intravenous glucose.
February 1975, Journal of chronic diseases,
E K Syvälahti, and J H Kanto
[The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
January 1970, Acta diabetologica latina,
Copied contents to your clipboard!